| scholarly article | Q13442814 |
| P50 | author | Michelle M Mielke | Q60909929 |
| P2093 | author name string | X Guo | |
| H Shao | |||
| P P Zandi | |||
| M Waern | |||
| I Skoog | |||
| L Lissner | |||
| C Björkelund | |||
| D R Gustafson | |||
| S Östling | |||
| P2860 | cites work | Brain circuits regulating energy homeostasis | Q24569806 |
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease | Q28216782 | ||
| Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease | Q28268162 | ||
| Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later | Q33621287 | ||
| Olfactory impairment in presymptomatic Alzheimer's disease | Q33802937 | ||
| Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model | Q33915820 | ||
| A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease | Q34094305 | ||
| Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo | Q34514599 | ||
| Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons | Q34663462 | ||
| Change in blood pressure and incident dementia: a 32-year prospective study | Q35104417 | ||
| The epidemiologic study of dementia: a life-long quest? | Q36003492 | ||
| Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study | Q36955424 | ||
| Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis | Q37151717 | ||
| Relation of plasma lipids to Alzheimer disease and vascular dementia | Q37227535 | ||
| Adiposity indicators and dementia over 32 years in Sweden. | Q37420394 | ||
| Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study | Q44438334 | ||
| Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology | Q44521339 | ||
| Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study | Q44949032 | ||
| Midlife cardiovascular risk factors and risk of dementia in late life | Q45236740 | ||
| High total cholesterol levels in late life associated with a reduced risk of dementia. | Q46505847 | ||
| Serum cholesterol and risk of Alzheimer disease: a community-based cohort study. | Q46745937 | ||
| Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol | Q48161830 | ||
| Midlife respiratory function and Incidence of Alzheimer's disease: a 29-year longitudinal study in women | Q48630268 | ||
| Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. | Q51908156 | ||
| A population-based study of dementia in 85-year-olds. | Q52038432 | ||
| The study of women in Gothenburg 1968-1969--a population study. General design, purpose and sampling results | Q69549457 | ||
| Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study | Q73076616 | ||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 1888-1895 | |
| P577 | publication date | 2010-11-10 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | The 32-year relationship between cholesterol and dementia from midlife to late life | |
| P478 | volume | 75 |
| Q30251902 | Alzheimer's disease and diet: a systematic review |
| Q38071004 | Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways |
| Q50063689 | Association of midlife lipids with 20-year cognitive change: A cohort study |
| Q37897218 | CNS regulation of plasma cholesterol. |
| Q38643560 | Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia |
| Q94599763 | Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis |
| Q92447867 | Changes in Metabolic Syndrome Status and Risk of Dementia |
| Q50708978 | Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years. |
| Q33752058 | Circulating biomarkers that predict incident dementia |
| Q89288249 | Clarifying dementia risk factors: treading in murky waters |
| Q56999967 | Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: An update |
| Q36966514 | Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention. |
| Q36587136 | Dyslipidemia and the risk of Alzheimer's disease |
| Q36429211 | Early adult to midlife cardiovascular risk factors and cognitive function |
| Q94464989 | Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy? |
| Q26749493 | Endocrine Risk Factors for Cognitive Impairment |
| Q90456215 | Evaluation of the Concurrent Trajectories of Cardiometabolic Risk Factors in the 14 Years Before Dementia |
| Q28655720 | Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis |
| Q64361136 | Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease |
| Q39236887 | Glucose level decline precedes dementia in elderly African Americans with diabetes |
| Q37337605 | Hypertension, brain damage and cognitive decline. |
| Q49130753 | Impacts of High Serum Total Cholesterol Level on Brain Functional Connectivity in Non-Demented Elderly |
| Q56992661 | Investigating the relationship between DNA methylation age acceleration and risk factors for Alzheimer's disease |
| Q91675640 | Is Alzheimer's Disease Risk Modifiable? |
| Q54943031 | Is late-onset Alzheimer's disease really a disease of midlife? |
| Q37064329 | KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients |
| Q39497338 | Late-Life Vascular Risk Factors and Alzheimer Disease Neuropathology in Individuals with Normal Cognition |
| Q92000726 | Low Cholesterol Level Linked to Reduced Semantic Fluency Performance and Reduced Gray Matter Volume in the Medial Temporal Lobe |
| Q26799893 | Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment |
| Q41002434 | Metabolic parameters and cognitive function in a cohort of older diabetic patients |
| Q47983600 | Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology. |
| Q46601342 | Mild hypercholesterolemia, normal plasma triglycerides, and normal glucose levels across dementia staging in Alzheimer's disease: a clinical setting-based retrospective study |
| Q100763997 | Multi-time-point data preparation robustly reveals MCI and dementia risk factors |
| Q91246348 | Nutrients in Alzheimer's Disease: The Interaction of Diet, Drugs and Disease |
| Q47574382 | Nutrition research in cognitive impairment/dementia, with a focus on soya and folate |
| Q51765060 | Outcome age-based prediction of successful cognitive aging by total cholesterol. |
| Q30235369 | Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis |
| Q37632619 | Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease |
| Q36841850 | Regulation of cerebral cholesterol metabolism in Alzheimer disease |
| Q88265451 | Relationship of Lipids and Lipid-Lowering Medications With Cognitive Function: The Multi-Ethnic Study of Atherosclerosis |
| Q39444002 | Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease. |
| Q44613096 | Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study. |
| Q56981421 | Serum Cholesterol and Incident Alzheimer's Disease: Findings from the Adult Changes in Thought Study |
| Q37664042 | Sex differences in the associations between lipid levels and incident dementia |
| Q37585688 | Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example |
| Q24186591 | Statins for the prevention of dementia |
| Q38287482 | Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies |
| Q35687324 | The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease |
| Q35888120 | The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort |
| Q47660161 | The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old. |
| Q34415410 | The relationship between cholesterol and cognitive function is homocysteine-dependent |
| Q37589656 | Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis |
| Q64248089 | Variability in Total Cholesterol Concentration Is Associated With the Risk of Dementia: A Nationwide Population-Based Cohort Study |
| Q37622100 | Vascular risk factors and cognitive decline in a population sample |
Search more.